Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Transcatheter arterial embolization in unresectable hepatocellular carcinoma.

Literature DB >> 2171771

Transcatheter arterial embolization in unresectable hepatocellular carcinoma.

R Yamada¹, K Kishi, T Sonomura, M Tsuda, S Nomura, M Satoh.

Abstract

Seven hundred thirty-nine patients with unresectable hepatocellular carcinoma have been treated by transcatheter arterial chemoembolization using gelatin sponge particles soaked in a solution of Mitomycin C and Adriamycin. This therapy can be equal or superior to surgical resection and serves both as embolic therapy and targeted chemotherapy.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1990 PMID： 2171771 DOI： 10.1007/BF02575464

Source DB: PubMed Journal: Cardiovasc Intervent Radiol ISSN： 0174-1551 Impact factor: 2.740

16 in total

Review 1. Primary liver cancer. Quadrennial review lecture.

Authors: K Okuda
Journal: Dig Dis Sci Date: 1986-09 Impact factor: 3.199

2. [Usefulness of a 5Fr-sized preshaped balloon catheter--so called "interventional balloon catheter"].

Authors: M Satoh; K Kitayama; K Kishi; Y Shioyama; M Tsuda; M Terada; J Hamachi; M Maeda; M Daimon; H Tanaka
Journal: Nihon Igaku Hoshasen Gakkai Zasshi Date: 1988-07-25

3. Hepatic arterial embolization for hepatocellular carcinoma. Comparison of CT scans and resected specimens.

Authors: K Takayasu; N Moriyama; Y Muramatsu; M Suzuki; T Yamada; K Kishi; H Hasagawa; N Okazaki
Journal: Radiology Date: 1984-03 Impact factor: 11.105

4. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma: a preliminary report.

Authors: T Konno; H Maeda; K Iwai; S Tashiro; S Maki; T Morinaga; M Mochinaga; T Hiraoka; I Yokoyama
Journal: Eur J Cancer Clin Oncol Date: 1983-08

5. Hepatic artery embolization in 120 patients with unresectable hepatoma.

Authors: R Yamada; M Sato; M Kawabata; H Nakatsuka; K Nakamura; S Takashima
Journal: Radiology Date: 1983-08 Impact factor: 11.105

6. Transcatheter arterial embolization for hepatocellular carcinoma. Benefits and limitations for unresectable cases with liver cirrhosis evaluated by comparison with other conservative treatments.

Authors: Y Sato; K Fujiwara; I Ogata; Y Ohta; S Hayashi; Y Oka; S Furui; H Oka
Journal: Cancer Date: 1985-06-15 Impact factor: 6.860

7. Hepatic artery embolization in the treatment of hepatic neoplasms.

Authors: V P Chuang; S Wallace
Journal: Radiology Date: 1981-07 Impact factor: 11.105

8. Hepatocellular carcinoma treated by transcatheter arterial embolization: progress evaluated by computed tomography.

Authors: S Furui; K Otomo; Y Itai; M Iio
Journal: Radiology Date: 1984-03 Impact factor: 11.105

Review 9. Epidemiology of hepatocellular carcinoma.

Authors: V K Rustgi
Journal: Gastroenterol Clin North Am Date: 1987-12 Impact factor: 3.806

Review 10. Regional chemotherapy of neoplastic diseases.

Authors: W D Ensminger; J W Gyves
Journal: Pharmacol Ther Date: 1983 Impact factor: 12.310

23 in total

1. Chemoembolization in the treatment of hepatic malignancy.

Authors: M J Pentecost; G P Teitelbaum
Journal: West J Med Date: 1992-03

2. Radiosurgery for tumors and arteriovenous malformations of the brain.

Authors: B R Griffin
Journal: West J Med Date: 1992-03

3. Vasodilator and exercise cardiac perfusion scintigraphy.

Authors: R W Henderson
Journal: West J Med Date: 1992-03

4. Preparation and characterization of gelatin sponge millispheres from air-in-water-in-oil-type emulsions.

Authors: Noboru Yamashita; Satoshi Izumikawa; Akira Takagi; Haruyuki Arakawa; Tatsuyoshi Wakasawa; Atsushi Maruyama
Journal: J Mater Sci Mater Med Date: 2009-01-10 Impact factor: 3.896

Review 5. Liver-spleen infarcts following transcatheter chemoembolization: a case report and review of the literature on adverse effects.

Authors: S E Cohen; R Safadi; A Verstandig; A Eid; T Sasson; L Symmer; D Shouval
Journal: Dig Dis Sci Date: 1997-05 Impact factor: 3.199

6. A high value of serum des-γ-carboxy prothrombin before hepatocellular carcinoma treatment can be associated with long-term liver dysfunction after treatment.

Authors: Masaya Saito; Yasushi Seo; Yoshihiko Yano; Akira Miki; Masaru Yoshida; Takeshi Azuma
Journal: J Gastroenterol Date: 2012-03-24 Impact factor: 7.527

7. Risk factors for local tumor recurrence after segmental transarterial chemoembolization for hepatocellular carcinoma: the importance of tumor located in the segmental border zone.

Authors: Yun Ku Cho; Jin Wook Chung; Yong-Sik Ahn; Yoon-Ok Park; Jae Kyun Kim; Jong-Hoon Byun
Journal: Korean J Radiol Date: 2006 Oct-Dec Impact factor: 3.500

8. Local recurrence of hepatocellular carcinoma after segmental transarterial chemoembolization: risk estimates based on multiple prognostic factors.

Authors: Seung Hyun Park; Yun Ku Cho; Yong-Sik Ahn; Yoon-Ok Park; Jae Kyun Kim; Jin Wook Chung
Journal: Korean J Radiol Date: 2007 Mar-Apr Impact factor: 3.500

9. [Palliative therapy of primary liver tumors].

Authors: C Kelm; K Henneking; T Zimmermann; M Vollerthun; W Padberg
Journal: Langenbecks Arch Chir Date: 1993

10. Multivariate analysis of the predictors of survival for patients with hepatocellular carcinoma undergoing transarterial chemoembolization: focusing on superselective chemoembolization.

Authors: Suk Kyeong Ji; Yun Ku Cho; Yong Sik Ahn; Mi Young Kim; Yoon Ok Park; Jae Kyun Kim; Wan Tae Kim
Journal: Korean J Radiol Date: 2008 Nov-Dec Impact factor: 3.500